ACHIEVE LIFE SCIENCES, INC. — Form 8-K
Filed July 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Achieve Life Sciences amended its Certificate of Incorporation effective July 6, 2026, increasing total authorized shares from an unspecified prior amount to 305,000,000 total shares: 300,000,000 common shares ($0.001 par value) and 5,000,000 preferred shares ($0.001 par value). The filing does not disclose the prior authorization levels, current outstanding shares, or intended use of the increased authorization.
Why this rating
Share authorization increase is routine capital management but lacks disclosure of current dilution or financing intent. Moderate opacity raises governance concern for ~$104M company.
See more from July 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.